Suppr超能文献

药物重定位:多沙唑嗪可减弱革兰氏阴性菌的毒力因子和生物膜形成。

Drug repositioning: doxazosin attenuates the virulence factors and biofilm formation in Gram-negative bacteria.

机构信息

Department of Natural Products, Faculty of Pharmacy, King Abdulaziz University, Jeddah, 21589, Saudi Arabia.

Centre for Artificial Intelligence in Precision Medicines, King Abdulaziz University, Jeddah, 21589, Saudi Arabia.

出版信息

Appl Microbiol Biotechnol. 2023 Jun;107(11):3763-3778. doi: 10.1007/s00253-023-12522-3. Epub 2023 Apr 20.

Abstract

The resistance development is an increasing global health risk that needs innovative solutions. Repurposing drugs to serve as anti-virulence agents is suggested as an advantageous strategy to diminish bacterial resistance development. Bacterial virulence is controlled by quorum sensing (QS) system that orchestrates the expression of biofilm formation, motility, and virulence factors production as enzymes and virulent pigments. Interfering with QS could lead to bacterial virulence mitigation without affecting bacterial growth that does not result in bacterial resistance development. This study investigated the probable anti-virulence and anti-QS activities of α-adrenoreceptor blocker doxazosin against Proteus mirabilis and Pseudomonas aeruginosa. Besides in silico study, in vitro and in vivo investigations were conducted to assess the doxazosin anti-virulence actions. Doxazosin significantly diminished the biofilm formation and release of QS-controlled Chromobacterium violaceum pigment and virulence factors in P. aeruginosa and P. mirabilis, and downregulated the QS encoding genes in P. aeruginosa. Virtually, doxazosin interfered with QS proteins, and in vivo protected mice against P. mirabilis and P. aeruginosa. The role of the membranal sensors as QseC and PmrA was recognized in enhancing the Gram-negative virulence. Doxazosin downregulated the membranal sensors PmR and QseC encoding genes and could in silico interfere with them. In conclusion, this study preliminary documents the probable anti-QS and anti-virulence activities of doxazosin, which indicate its possible application as an alternative or in addition to antibiotics. However, extended toxicological and pharmacological investigations are essential to approve the feasible clinical application of doxazosin as novel efficient anti-virulence agent. KEY POINTS: • Anti-hypertensive doxazosin acquires anti-quorum sensing activities • Doxazosin diminishes the virulence of Proteus mirabilis and Pseudomonas aeruginosa • Doxazosin could dimmish the bacterial espionage.

摘要

耐药性的发展是一个日益严重的全球健康风险,需要创新的解决方案。将药物重新用于作为抗毒力剂是一种减少细菌耐药性发展的有利策略。细菌的毒力受群体感应 (QS) 系统控制,该系统协调生物膜形成、运动和毒力因子产生(如酶和有毒色素)的表达。干扰 QS 可能导致细菌毒力减弱,而不影响细菌生长,从而不会导致细菌耐药性发展。本研究调查了α-肾上腺素能受体阻滞剂多沙唑嗪对奇异变形杆菌和铜绿假单胞菌的可能抗毒力和抗 QS 活性。除了计算机研究外,还进行了体外和体内研究来评估多沙唑嗪的抗毒力作用。多沙唑嗪显著减少了铜绿假单胞菌和奇异变形杆菌的生物膜形成和 QS 控制的变色杆菌色素和毒力因子的释放,并下调了铜绿假单胞菌的 QS 编码基因。实际上,多沙唑嗪干扰了 QS 蛋白,并在体内保护了小鼠免受奇异变形杆菌和铜绿假单胞菌的侵害。膜传感器 QseC 和 PmrA 的作用被认为可以增强革兰氏阴性菌的毒力。多沙唑嗪下调了膜传感器 PmR 和 QseC 编码基因,并可以在计算机上干扰它们。总之,本研究初步记录了多沙唑嗪可能的抗 QS 和抗毒力活性,表明其可能作为抗生素的替代或补充物应用。然而,需要进行扩展的毒理学和药理学研究,以批准多沙唑嗪作为新型有效抗毒力剂的可行临床应用。 关键点: • 抗高血压药物多沙唑嗪获得抗群体感应活性 • 多沙唑嗪降低奇异变形杆菌和铜绿假单胞菌的毒力 • 多沙唑嗪可以减弱细菌的间谍活动。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验